| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 01/21/2010 | US20100015107 Expression elements |
| 01/21/2010 | US20100015096 Fusion Proteins of Mycobacterium Tuberculosis |
| 01/21/2010 | US20100015089 Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation |
| 01/21/2010 | US20100015087 Hiv-1 tat, or derivatives thereof for prophylactic and therapeutic vaccination |
| 01/21/2010 | US20100015070 Use of natural, recombinant and synthetic resilins in cosmetics |
| 01/21/2010 | DE10004815B4 Menschliche intestinale Natriumphosphat-Kotransporter Human intestinal sodium phosphate cotransporter |
| 01/21/2010 | CA2730897A1 Phosphopeptides and use of the same |
| 01/21/2010 | CA2730741A1 Self-replicating vector lacking an antibiotic-resistance gene |
| 01/20/2010 | EP2145962A2 Process for the manufacture of eptifibatide |
| 01/20/2010 | EP2145954A1 Anti-A33 antibody |
| 01/20/2010 | EP2145953A1 Cell-free protein synthesis system originating in cultured mammalian cells |
| 01/20/2010 | EP2145897A2 Therapeutic methods and compositions based on serrate proteins and nucleic acids |
| 01/20/2010 | EP1860184B1 Novel polypeptide, polynucleotide encoding the polypeptide and use the polypeptide and polynucleotide |
| 01/20/2010 | EP1783203B1 Process for producing substances |
| 01/20/2010 | EP1745141B1 O-linked glycoforms of faktor vii and method to manufacture them |
| 01/20/2010 | EP1597380B1 Expression of class 2 mannosidase and class iii mannosidase in lower eukaryotic cells |
| 01/20/2010 | EP1379272B1 Monoclonal antibodies directed against molecular mimetics of meningococcal b epitopes |
| 01/20/2010 | EP1257649B1 Corynebacterium glutamicum genes encoding metabolic pathway proteins |
| 01/20/2010 | EP1188830B1 Novel hemopoietin receptor protein ,nr10 |
| 01/20/2010 | EP1151112B1 Heat-inducible promoter |
| 01/20/2010 | EP1117419B1 Contortrostatin (cn) and methods for its use in preventing metastasis and other conditions |
| 01/20/2010 | EP0971724B1 Expression of active human factor ix in mammary tissue of transgenic animals |
| 01/20/2010 | EP0917538B1 Eukaryotic cells expressing at their surface at least an hla-g isoform and their applications |
| 01/20/2010 | CN101629204A Methods for producing biological substances in enzyme-deficient mutants of aspergillus |
| 01/20/2010 | CN100582230C Expression of endogenous genes by non-homologons recombination of a vector construct with cellular DNA |
| 01/20/2010 | CN100582214C Donkey-hide gelatin polypeptide wine and production process thereof |
| 01/19/2010 | US7650276 System and method for dynamic data binding in distributed applications |
| 01/19/2010 | US7649085 Saquinavir conjugates and antibodies useful in immunoassay |
| 01/19/2010 | US7649084 Genetic engineering; cat thyrotropin beta -subunit polypeptide and polynucleotide; hyperthyroidism |
| 01/19/2010 | US7649081 Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids and therapeutic uses therefor |
| 01/19/2010 | US7648964 In response to an insult or injury, in protecting against ocular inflammation, and in promoting ocular wound repair; glycoprotein |
| 01/19/2010 | US7648958 Factor VIII/vWF-complex and methods of purifying same |
| 01/19/2010 | US7648708 Streptococcus pneumoniae proteins and nucleic acid molecules |
| 01/19/2010 | US7648701 Peptide composition as immunogen for the treatment of allergy |
| 01/19/2010 | CA2123492C Lymphoid antigen cd30 |
| 01/16/2010 | CA2671787A1 Methods for producing secreted proteins |
| 01/14/2010 | WO2010005068A1 Pharmaceutical composition for treatment and prevention of cancer |
| 01/14/2010 | WO2010003235A1 Soluble recombinant influenza antigens |
| 01/14/2010 | WO2009126623A3 Expression of heterologous sequences |
| 01/14/2010 | WO2009073551A3 Lac expression system |
| 01/14/2010 | WO2008157379A8 Covalent diabodies and uses thereof |
| 01/14/2010 | WO2008115887A3 Labeled biomolecular compositions and methods for the production and uses thereof |
| 01/14/2010 | WO2006014505A9 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
| 01/14/2010 | US20100011456 Nucleic Acids and Proteins and Methods for Making and Using Them |
| 01/14/2010 | US20100011454 Human artificial chromosome (hac) vector and human cell medicine comprising same |
| 01/14/2010 | US20100010207 Rna interference mediating small rna molecules |
| 01/14/2010 | US20100010200 for Systemic Inflammatory Response Syndrome (SIRS), including severe sepsis, septic shock and sepsis related to cardiac dysfunction |
| 01/14/2010 | US20100010196 Compositions and methods for non-targeted activation of endogenous genes |
| 01/14/2010 | US20100010195 Novel tumor necrosis factor receptor homolog and nucleic acids encoding the same |
| 01/14/2010 | US20100009922 Hypotensive peptides from soy proteins and method of preparation |
| 01/14/2010 | US20100009917 Modulating Enzymatic Processes by Addition of Diolcontaining Substances |
| 01/14/2010 | US20100009909 Peptides binding the phosphatase 2a protein |
| 01/14/2010 | US20100009902 Glycoconjugation Using Saccharyl Fragments |
| 01/14/2010 | US20100009857 Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries |
| 01/14/2010 | US20100009439 ANTI-IGF-I RECEPTOR ANTIBODIES, DNAs, VECTORS, HOST CELLS AND GENETIC CONSTRUCTS |
| 01/14/2010 | US20100009425 Glycoprotein synthesis |
| 01/14/2010 | US20100009410 Methods and Constructs for Expressing Polypeptide Multimers in Eukaryotic Cells Using Alternative Splicing |
| 01/14/2010 | US20100009409 Molecular variant fibrinogen fusion proteins |
| 01/14/2010 | US20100009408 Induction of Gene Expression Using a High Concentration Sugar Mixture |
| 01/14/2010 | US20100009407 comprising an N-terminally attached tag derived from highly basic proteins from thermophilic bacteria; produced in high yields and can be effectively separated from modified protein after use; increase expression level, solubility or correct folding of target protein and to facilitate easy purifification |
| 01/14/2010 | US20100009406 Gene sequence coding formyl peptide receptor binding protein; diagnosing cancer, wound bone healing, obesity, acute heart failure, hypotension, hypertension, urinary retention, osteoporosis, restenosis, atherosclerosis, thrombosis, cardiovascular, autoimmune and nervous system disorders |
| 01/14/2010 | US20100009405 Biosynthetic process for the preparation of gallidermin |
| 01/14/2010 | US20100009384 Acyltransferase -1 (ACTR-1); for identifying modulators or are useful themselves as compositions for diagnosis and treatment of disease or disorder that arise from malfunction of the regulation of triacylglycerol (triglyceride) and phospholipid biosynthesis e.g. atherosclerosis; cardiovascular disorders |
| 01/14/2010 | US20100009346 Lafora's disease gene |
| 01/14/2010 | US20100008906 Cripto binding molecules |
| 01/14/2010 | US20100008895 used in vaccines against A. salmonicida infections such as fish disease furunculosis; ADP-ribosylating toxins |
| 01/14/2010 | US20100008851 Anti-gd2 antibodies and methods and uses related thereto |
| 01/14/2010 | DE102008029688A1 Determining and identifying variant of Clostridium difficile strain in sample, comprises obtaining sample, contacting sample with antibody, detecting antibody reaction, comparing obtained reaction pattern with reference and correlating |
| 01/14/2010 | CA2730201A1 Pharmaceutical composition for treatment and prevention of cancer |
| 01/14/2010 | CA2730171A1 Soluble recombinant influenza antigens |
| 01/14/2010 | CA2729949A1 Prostaglandin e2 dual variable domain immunoglobulins and uses thereof |
| 01/13/2010 | EP2143804A1 Method for production of glutathione or gamma-glutamylcysteine |
| 01/13/2010 | EP2143795A2 Anti-CD20 monoclonal antibody |
| 01/13/2010 | EP2143786A1 Method for producing dipeptide |
| 01/13/2010 | EP2143734A1 The functional epitope of osteopontin, the anti-osteoponin monoclonal antibody and use thereof |
| 01/13/2010 | EP2143733A1 ANTI-IL-20 antibodies and binding partners and methods of using in inflammation |
| 01/13/2010 | EP2143438A1 Compositions and methods for the diagnosis and treatment of tumor |
| 01/13/2010 | EP2143437A1 Compositions and methods for the diagnosis and treatment of tumor |
| 01/13/2010 | EP2142660A2 Methods and systems for o-glycosylating proteins |
| 01/13/2010 | EP2142634A1 Optimization of colicin production |
| 01/13/2010 | EP2142565A1 Crystalline anti-human il-12 antibodies |
| 01/13/2010 | EP2142563A1 Bis-met histones |
| 01/13/2010 | EP1394253B1 Anti-human ovarian cancer -anti-cd3 bispecific antibody |
| 01/13/2010 | EP1339744B1 Production of recombinant bmp-2 |
| 01/13/2010 | EP1117802B1 Nucleic acid molecules which code a branching enzyme from bacteria of the genus neisseria, and a method for producing alpha-1,6-branched alpha-1,4-glucans |
| 01/13/2010 | CN101624614A Culture method for anti-CD25 antibody |
| 01/13/2010 | CN101624613A Bio-modification preparation method for improving activity of laver phycoerythrin |
| 01/13/2010 | CN100580088C Enzyme method for hydrolyzing casein and synchronous preparation of phosphopeptide and non-phosphopeptide |
| 01/13/2010 | CN100580087C Conjugation of peptides |
| 01/13/2010 | CN100580084C Combinatorial libraries of proteins having the scaffold structure of C-type lectin-like domains |
| 01/13/2010 | CN100580080C Corona-virus-like particles comprising functionally deleted genomes |
| 01/13/2010 | CN100579989C Interfusion protein between diphtheria toxin and GM-CSF mutant, coded gene and application |
| 01/13/2010 | CN100579988C Interfusion protein between diphtheria toxin and GM-CSF mutant, coded gene and application |
| 01/13/2010 | CN100579986C Production method of insulinotropic secretion peptide GLP-1(7-36) and GLP-1 analog |
| 01/12/2010 | US7645613 Diagnosing systemic inflammatory response syndrome; biomarker |
| 01/12/2010 | US7645609 Method for controlling sialylation of proteins produced by mammalian cells |
| 01/12/2010 | US7645602 Host cell comprising a recombinant nucleic acid coding for a vitamin K epoxide reductase (VKOR) |
| 01/12/2010 | US7645600 Compositions and methods for enhanced bacterial exopolysaccharide production |
| 01/12/2010 | US7645588 Human or rodent Stromal Interacting Molecule (STIM) 1 protein; for treatment of diseases associated with calcium dysregulation |
| 01/12/2010 | CA2471105C Stable isotope-labeled amino acid and method for incorporating the same into target protein, nmr method for the structural analysis of protein and method for producing regio-selective stable isotope-labeled fumaric acid and tartaric acid |